0001062993-20-000108.txt : 20200110 0001062993-20-000108.hdr.sgml : 20200110 20200110194152 ACCESSION NUMBER: 0001062993-20-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200106 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUTCHISON PATRICK CENTRAL INDEX KEY: 0001673870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 20522333 MAIL ADDRESS: STREET 1: C/O BIOSPECIFICS TECHNOLOGIES CORP STREET 2: 2 RIGHTER PARKWAY SUITE 200 CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER NAME: FORMER CONFORMED NAME: Hutchison Patrick DATE OF NAME CHANGE: 20160504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2020-01-06 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001673870 HUTCHISON PATRICK C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 56.21 2020-01-06 4 A 0 10000 0.00 A 2030-01-06 Common Stock 10000 10000 D The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. This transaction is reported late due to delayed receipt of the Reporting Person's EDGAR access codes. The stock options vest ratably over the four-year period following the date of grant, January 6, 2020, subject to the Reporting Person's continued service to the employer through the vesting date. /s/ Patrick C. Hutchison, by Carl A. Valenstein, attorney-in-fact 2020-01-10